Case Report
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Mar 6, 2024; 12(7): 1333-1338
Published online Mar 6, 2024. doi: 10.12998/wjcc.v12.i7.1333
Heterochronous multiple primary prostate cancer and lymphoma: A case report
Jin-Long Liang, Yu-Qing Bu, Li-Li Peng, Hong-Zhen Zhang
Jin-Long Liang, Yu-Qing Bu, Li-Li Peng, Hong-Zhen Zhang, Department of Oncology, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China
Author contributions: Liang JL wrote the article; Bu YQ collected the literature; Peng LL revised the format of the article; Zhang HZ revised and is responsible for the full text.
Supported by Key Research and Development Projects in Hebei Province, No. 21377795D; and Natural Science Foundation of Hebei Province, No. H2021307017.
Informed consent statement: We have obtained the informed consent of the patient's family.
Conflict-of-interest statement: There is no conflict of interest in this report.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hong-Zhen Zhang, PhD, Doctor, Department of Oncology, Hebei General Hospital, No. 348 Heping West Road, Xinhua District, Shijiazhuang 050051, Hebei Province, China. 1256596529@qq.com
Received: November 12, 2023
Peer-review started: November 12, 2023
First decision: January 9, 2024
Revised: January 17, 2024
Accepted: February 6, 2024
Article in press: February 6, 2024
Published online: March 6, 2024
Core Tip

Core Tip: We report the case of a 77-year-old male patient diagnosed with prostate cancer presenting with dysuria with hematuria. He received radiation therapy and 1 year of endocrine therapy with an efficacy evaluation of partial response. 7 years later, he was diagnosed with diffuse large B-cell lymphoma of the rectum with lung metastases presenting with lower abdominal pain and constipation, and was treated with 2 cycles of chemotherapy on the CHOP regimen with an efficacy evaluation of remission. He was not treated again for personal reasons and unfortunately, the patient died 1 year later.